0001973141-23-000161.txt : 20230731 0001973141-23-000161.hdr.sgml : 20230731 20230731161255 ACCESSION NUMBER: 0001973141-23-000161 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230731 DATE AS OF CHANGE: 20230731 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 231127549 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Roth David CENTRAL INDEX KEY: 0001599014 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001599014 XXXXXXXX LIVE 0001556263 Syros Pharmaceuticals, Inc. 001-37813 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340 Roth David Officer Chief Medical Officer COMMON UBS Financial Services, Inc.

1000 Harbor Blvd 3rd Floor Weehawken NJ 07086

7348 29024.60 20595503 07/31/2023 Nasdaq COMMON 03/31/2022 RSU Issuer N 5971 03/31/2022 NA COMMON 03/31/2023 RSU Issuer N 1377 03/31/2023 NA Y 07/31/2023 03/27/2023 /s/ UBS Financial Services Inc, as attorney-in-fact for David A. Roth